Niagen Bioscience, Inc. (NAGE)

Paramount Global Revenue

Niagen Bioscience had revenue of $31.12M in the quarter ending June 30, 2025, with 36.84% growth. This brings the company's revenue in the last twelve months to $116.30M, up 35.89% year-over-year. In the year 2024, Niagen Bioscience had annual revenue of $99.60M with 19.18% growth.

• Revenue (ttm): $116.30M
• Revenue Growth: +35.89%
• P/S Ratio: 6.48
• Revenue / Employee: $1,118,298
• Employees: 104
• Market Cap: 787.21M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	99.60M	16.03M	19.18%
Dec 31, 2023	83.57M	11.52M	15.99%
Dec 31, 2022	72.05M	4.60M	6.82%
Dec 31, 2021	67.45M	8.19M	13.82%
Dec 31, 2020	59.26M	12.97M	28.01%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.